Back
Western Copper & Gold Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
33
WRN.TO
Western Copper & Gold
Last Price:
1.57
Seasonality Move:
16.46%
Buy
60
SRPT
Sarepta Therapeutics
Last Price:
138.01
Seasonality Move:
14.88%
Sell
33
Western Copper & Gold (WRN.TO)
is a Sell
Is Western Copper & Gold a Buy, Sell or Hold?
- The current Western Copper & Gold [WRN.TO] share price is $1.57. The Score for WRN.TO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- WRN.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WRN.TO Stock Price Chart
What is Western Copper & Gold's stock price today?
-
The Western Copper & Gold share price today is $1.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WRN.TO is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $137.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
WRN.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 44.94 | Sell |
Chaikin Money Flow: | -16879 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.53 - 1.67) | Sell |
Bollinger Bands (100): | (1.52 - 1.66) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 69.97 | Buy |
Chaikin Money Flow: | 2429824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.85 - 129.69) | Buy |
Bollinger Bands (100): | (119.21 - 142.01) | Buy |
WRN.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.59 | Sell |
20-day SMA: | 1.61 | Sell |
50-day SMA: | 1.63 | Sell |
200-day SMA: | 1.72 | Sell |
8-day EMA: | 1.6 | Sell |
20-day EMA: | 1.61 | Sell |
50-day EMA: | 1.61 | Sell |
200-day EMA: | 1.69 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.25 | Buy |
20-day SMA: | 117.78 | Buy |
50-day SMA: | 122.17 | Buy |
200-day SMA: | 130.04 | Buy |
8-day EMA: | 121.1 | Buy |
20-day EMA: | 119.12 | Buy |
50-day EMA: | 122.54 | Buy |
200-day EMA: | 126.1 | Buy |
Western Copper & Gold Earnings Growth & WRN.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and an increase next year of $0.01 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
Western Copper & Gold Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |